Latest Strategy Changes News

D3 Energy has secured formal acceptance of its Production Right Application for the ER315 permit in South Africa, marking a pivotal step toward production. The company also broadened its portfolio with new helium and hydrogen permits in Australia and began trading on the US OTCQX market.

Synertec Corporation has reported its strongest first quarter since FY19, driven by a 13% revenue increase and a new order for its Powerhouse microgrid units from Santos. The company’s engineering division also shows promising expansion with a robust project pipeline.

Horizon Oil’s recent acquisition of Thai gas assets and a decade-long permit extension at Maari have propelled production and reserves, underpinning a strong financial quarter and sustained shareholder returns.

CONNEQT Health reported a $2.6 million operating cash outflow in the September quarter but secured $2 million through a convertible note, while expecting a $1.6 million R&D tax refund to shore up liquidity.

Centuria Office REIT reported its strongest quarterly leasing performance to date, signing over 23,400 sqm across key properties while maintaining solid occupancy and reaffirming its FY26 financial guidance.

Wrkr Ltd has reported a strong start to FY26 with its third consecutive quarter of positive operating cash flow and a successful $15 million capital raise, positioning the fintech for accelerated growth ahead of major client launches.

Tambourah Metals reports breakthrough high-grade gold discoveries at Beatty Park South and Tambourah King, alongside promising critical minerals assays at Speewah North, underpinning an aggressive exploration push in Western Australia.

Global Lithium Resources Limited has achieved major milestones this quarter with a Native Title Mining Agreement and Mining Lease granted for its Manna Lithium Project, while exploration at Marble Bar reveals encouraging signs of a large gold system.

Harmoney has reaffirmed its FY26 profit guidance, aiming for a $12 million cash NPAT, while unveiling a new secured auto loan product designed to disrupt the car finance market.

Paradigm Biopharmaceuticals has initiated dosing in its pivotal Phase 3 trial for knee osteoarthritis pain, backed by a strong cash position and strategic portfolio expansion. The company targets accelerated recruitment and a mid-2026 interim analysis.

Vintage Energy reported a 24% drop in quarterly sales revenue to $0.9 million alongside a 20% production decline, while initiating a Production Uplift Program targeting its Southern Flank gas fields and maintaining steady 2P reserves at 12.5 MMboe.

CurveBeam AI reports a 33% increase in Q1 FY26 purchase orders, secures A$6.5 million in new funding, and finalizes a strategic joint venture for China distribution and manufacturing rights.